Literature DB >> 7729523

An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B.

M Andersson1, T Curstedt, H Jörnvall, J Johansson.   

Abstract

The tumour-lysing and antimicrobial polypeptide NK-lysin and the pulmonary surfactant-associated polypeptide SP-B exhibit 24% residue identities (49% similarities), including six half-cystine residues in the same disulphide bonding pattern, and similar far-UV circular dichroism spectra corresponding to 45-55% alpha-helix and 20-25% beta-sheet structures. From this, we conclude that the conformations of NK-lysin and SP-B are similar. In contrast, the functional properties of the two proteins are dissimilar: SP-B does not exhibit antibacterial activity and NK-lysin does not significantly effect phospholipid spreading at an air/water interface. Saposins, which solubilize lipids and activate lysosomal hydrolases, the pore-forming amoebapores, and parts of acid sphingomyelinase and acyloxyacylhydrolase, also share 18-27% sequence identities with NK-lysin (and SP-B), including the six conserved half-cystine residues. The inclusion of NK-lysin extends the family of saposin-like polypeptides, all members of which appear to interact with lipids. Strictly conserved structural features with implications for helix topology and lipid interactions are observed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729523     DOI: 10.1016/0014-5793(95)00268-e

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  Direct simulation of protein-mediated vesicle fusion: lung surfactant protein B.

Authors:  Svetlana Baoukina; D Peter Tieleman
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

Review 2.  Structures of naturally occurring circular proteins from bacteria.

Authors:  David J Craik; Norelle L Daly; Ivana Saska; Manuela Trabi; K Johan Rosengren
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

3.  An elevated level of cholesterol impairs self-assembly of pulmonary surfactant into a functional film.

Authors:  Zoya Leonenko; Simardeep Gill; Svetlana Baoukina; Luca Monticelli; Jana Doehner; Lasantha Gunasekara; Florian Felderer; Mathias Rodenstein; Lukas M Eng; Matthias Amrein
Journal:  Biophys J       Date:  2007-05-04       Impact factor: 4.033

4.  Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin.

Authors:  M Andersson; R Girard; P Cazenave
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 5.  Structure-function correlations of pulmonary surfactant protein SP-B and the saposin-like family of proteins.

Authors:  Bárbara Olmeda; Begoña García-Álvarez; Jesús Pérez-Gil
Journal:  Eur Biophys J       Date:  2012-09-21       Impact factor: 1.733

6.  Reverse-phase HPLC of the hydrophobic pulmonary surfactant proteins: detection of a surfactant protein C isoform containing Nepsilon-palmitoyl-lysine.

Authors:  M Gustafsson; T Curstedt; H Jörnvall; J Johansson
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

7.  Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH.

Authors:  Li Yang; Jan Johansson; Ross Ridsdale; Hanna Willander; Michael Fitzen; Henry T Akinbi; Timothy E Weaver
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

8.  Close mimicry of lung surfactant protein B by "clicked" dimers of helical, cationic peptoids.

Authors:  Michelle T Dohm; Shannon L Seurynck-Servoss; Jiwon Seo; Ronald N Zuckermann; Annelise E Barron
Journal:  Biopolymers       Date:  2009       Impact factor: 2.505

9.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

10.  Critical structural and functional roles for the N-terminal insertion sequence in surfactant protein B analogs.

Authors:  Frans J Walther; Alan J Waring; Jose M Hernandez-Juviel; Larry M Gordon; Zhengdong Wang; Chun-Ling Jung; Piotr Ruchala; Andrew P Clark; Wesley M Smith; Shantanu Sharma; Robert H Notter
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.